• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Slc7a5 改变了 Kvβ 对 Kv1.2 的调节。

Slc7a5 alters Kvβ-mediated regulation of Kv1.2.

机构信息

Department of Pharmacology, Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.

出版信息

J Gen Physiol. 2020 Jul 6;152(7). doi: 10.1085/jgp.201912524.

DOI:10.1085/jgp.201912524
PMID:32311044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7335012/
Abstract

The voltage-gated potassium channel Kv1.2 plays a pivotal role in neuronal excitability and is regulated by a variety of known and unknown extrinsic factors. The canonical accessory subunit of Kv1.2, Kvβ, promotes N-type inactivation and cell surface expression of the channel. We recently reported that a neutral amino acid transporter, Slc7a5, alters the function and expression of Kv1.2. In the current study, we investigated the effects of Slc7a5 on Kv1.2 in the presence of Kvβ1.2 subunits. We observed that Slc7a5-induced suppression of Kv1.2 current and protein expression was attenuated with cotransfection of Kvβ1.2. However, gating effects mediated by Slc7a5, including disinhibition and a hyperpolarizing shift in channel activation, were observed together with Kvβ-mediated inactivation, indicating convergent regulation of Kv1.2 by both regulatory proteins. Slc7a5 influenced several properties of Kvβ-induced inactivation of Kv1.2, including accelerated inactivation, a hyperpolarizing shift and greater extent of steady-state inactivation, and delayed recovery from inactivation. These modified inactivation properties were also apparent in altered deactivation of the Kv1.2/Kvβ/Slc7a5 channel complex. Taken together, these findings illustrate a functional interaction arising from simultaneous regulation of Kv1.2 by Kvβ and Slc7a5, leading to powerful effects on Kv1.2 expression, gating, and overall channel function.

摘要

电压门控钾通道 Kv1.2 在神经元兴奋性中起着关键作用,并且受到多种已知和未知的外在因素的调节。Kv1.2 的经典辅助亚基 Kvβ促进了通道的 N 型失活和细胞表面表达。我们最近报道了一种中性氨基酸转运蛋白 Slc7a5 改变了 Kv1.2 的功能和表达。在本研究中,我们在存在 Kvβ1.2 亚基的情况下研究了 Slc7a5 对 Kv1.2 的影响。我们观察到 Slc7a5 诱导的 Kv1.2 电流和蛋白表达的抑制作用在共转染 Kvβ1.2 时减弱。然而,Slc7a5 介导的门控效应,包括失活的解除和通道激活的超极化漂移,与 Kvβ介导的失活一起观察到,表明这两种调节蛋白对 Kv1.2 的调节作用是收敛的。Slc7a5 影响 Kvβ诱导的 Kv1.2 失活的几个特性,包括失活加速、超极化漂移和稳态失活程度增加以及失活后恢复的延迟。这些失活特性的改变也在 Kv1.2/Kvβ/Slc7a5 通道复合物的去激活中表现出来。总之,这些发现说明了 Kvβ和 Slc7a5 同时调节 Kv1.2 所产生的功能相互作用,导致对 Kv1.2 的表达、门控和整体通道功能产生强大的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/93107a681417/JGP_201912524_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/6bc803488a55/JGP_201912524_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/17ce3caacc5c/JGP_201912524_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/85b0391fc518/JGP_201912524_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/3ecdbc11b06f/JGP_201912524_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/0d15ba83a927/JGP_201912524_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/673e10c253f6/JGP_201912524_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/1a324195670b/JGP_201912524_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/0f90c468c8d8/JGP_201912524_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/10a3d5910051/JGP_201912524_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/93107a681417/JGP_201912524_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/6bc803488a55/JGP_201912524_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/17ce3caacc5c/JGP_201912524_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/85b0391fc518/JGP_201912524_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/3ecdbc11b06f/JGP_201912524_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/0d15ba83a927/JGP_201912524_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/673e10c253f6/JGP_201912524_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/1a324195670b/JGP_201912524_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/0f90c468c8d8/JGP_201912524_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/10a3d5910051/JGP_201912524_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db56/7335012/93107a681417/JGP_201912524_Fig7.jpg

相似文献

1
Slc7a5 alters Kvβ-mediated regulation of Kv1.2.Slc7a5 改变了 Kvβ 对 Kv1.2 的调节。
J Gen Physiol. 2020 Jul 6;152(7). doi: 10.1085/jgp.201912524.
2
Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels.药物结合与Kvβ1.3辅助亚基诱导的Kv1.5通道N型失活之间竞争的结构基础。
Mol Pharmacol. 2005 Oct;68(4):995-1005. doi: 10.1124/mol.105.011668. Epub 2005 Jul 15.
3
Control of Slc7a5 sensitivity by the voltage-sensing domain of Kv1 channels.Kv1 通道电压感应域对 Slc7a5 敏感性的控制。
Elife. 2020 Nov 9;9:e54916. doi: 10.7554/eLife.54916.
4
Separable effects of human Kvbeta1.2 N- and C-termini on inactivation and expression of human Kv1.4.人Kvβ1.2 N端和C端对人Kv1.4失活和表达的可分离效应
J Physiol. 1998 Oct 15;512 ( Pt 2)(Pt 2):325-36. doi: 10.1111/j.1469-7793.1998.325be.x.
5
Separable Kvbeta subunit domains alter expression and gating of potassium channels.可分离的Kvβ亚基结构域改变钾通道的表达和门控。
J Biol Chem. 1997 Oct 10;272(41):25824-31. doi: 10.1074/jbc.272.41.25824.
6
Slc7a5 regulates Kv1.2 channels and modifies functional outcomes of epilepsy-linked channel mutations.Slc7a5 调节 Kv1.2 通道,并修饰与癫痫相关的通道突变的功能结果。
Nat Commun. 2018 Oct 24;9(1):4417. doi: 10.1038/s41467-018-06859-x.
7
Interactions between the C-terminus of Kv1.5 and Kvβ regulate pyridine nucleotide-dependent changes in channel gating.Kv1.5 羧基末端与 Kvβ 相互作用调节通道门控的吡啶核苷酸依赖性变化。
Pflugers Arch. 2012 Jun;463(6):799-818. doi: 10.1007/s00424-012-1093-z. Epub 2012 Mar 17.
8
Protein kinase A phosphorylation alters Kvbeta1.3 subunit-mediated inactivation of the Kv1.5 potassium channel.蛋白激酶A磷酸化改变Kvβ1.3亚基介导的Kv1.5钾通道失活。
J Biol Chem. 1999 May 14;274(20):13928-32. doi: 10.1074/jbc.274.20.13928.
9
Modification of rat brain Kv1.4 channel gating by association with accessory Kvbeta1.1 and beta2.1 subunits.通过与辅助性Kvβ1.1和β2.1亚基结合对大鼠脑Kv1.4通道门控的修饰作用
Pflugers Arch. 1997 Dec;435(1):43-54. doi: 10.1007/s004240050482.
10
Functional coupling of intracellular calcium and inactivation of voltage-gated Kv1.1/Kvbeta1.1 A-type K+ channels.细胞内钙与电压门控性Kv1.1/Kvβ1.1 A型钾通道失活的功能偶联
Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15535-40. doi: 10.1073/pnas.0402081101. Epub 2004 Oct 14.

引用本文的文献

1
Competitive modulation of K1.2 gating by LMAN2 and Slc7a5.LMAN2和Slc7a5对K1.2通道门控的竞争性调节
FASEB J. 2024 Dec 15;38(23):e70243. doi: 10.1096/fj.202401737RR.
2
Regulation of Kv1.2 Redox-Sensitive Gating by the Transmembrane Lectin LMAN2.跨膜凝集素LMAN2对Kv1.2氧化还原敏感门控的调节
Function (Oxf). 2024 Nov 20;5(6). doi: 10.1093/function/zqae041.
3
Branched-Chain Amino Acids Deficiency Promotes Diabetic Neuropathic Pain Through Upregulating LAT1 and Inhibiting Kv1.2 Channel.支链氨基酸缺乏通过上调 LAT1 并抑制 Kv1.2 通道促进糖尿病神经病理性疼痛。

本文引用的文献

1
A potassium channel β-subunit couples mitochondrial electron transport to sleep.钾通道β亚基将线粒体电子传递与睡眠耦联。
Nature. 2019 Apr;568(7751):230-234. doi: 10.1038/s41586-019-1034-5. Epub 2019 Mar 20.
2
Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.人源 LAT1-4F2hc 异型氨基酸转运体复合物的结构。
Nature. 2019 Apr;568(7750):127-130. doi: 10.1038/s41586-019-1011-z. Epub 2019 Mar 13.
3
Slc7a5 regulates Kv1.2 channels and modifies functional outcomes of epilepsy-linked channel mutations.
Adv Sci (Weinh). 2024 Sep;11(33):e2402086. doi: 10.1002/advs.202402086. Epub 2024 Jul 1.
4
Bioinformatics Prediction and in vivo Verification Identify SLC7A5 as Immune Infiltration Related Biomarker in Breast Cancer.生物信息学预测与体内验证确定SLC7A5为乳腺癌免疫浸润相关生物标志物。
Cancer Manag Res. 2022 Aug 27;14:2545-2559. doi: 10.2147/CMAR.S370397. eCollection 2022.
5
Kv Channel Ancillary Subunits: Where Do We Go from Here?Kv 通道辅助亚基:我们从何处出发?
Physiology (Bethesda). 2022 Sep 1;37(5):0. doi: 10.1152/physiol.00005.2022.
6
Slc7a5 regulation of neural development.
Neural Regen Res. 2021 Oct;16(10):1994-1995. doi: 10.4103/1673-5374.308086.
7
Control of Slc7a5 sensitivity by the voltage-sensing domain of Kv1 channels.Kv1 通道电压感应域对 Slc7a5 敏感性的控制。
Elife. 2020 Nov 9;9:e54916. doi: 10.7554/eLife.54916.
8
Putative roles of SLC7A5 (LAT1) transporter in pain.溶质载体家族7成员5(LAT1)转运体在疼痛中的假定作用。
Neurobiol Pain. 2020 Jun 30;8:100050. doi: 10.1016/j.ynpai.2020.100050. eCollection 2020 Aug-Dec.
9
An ion channel in the company of a transporter.离子通道与转运蛋白为伴。
J Gen Physiol. 2020 Jul 6;152(7). doi: 10.1085/jgp.202012590.
Slc7a5 调节 Kv1.2 通道,并修饰与癫痫相关的通道突变的功能结果。
Nat Commun. 2018 Oct 24;9(1):4417. doi: 10.1038/s41467-018-06859-x.
4
Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies.KCNA2 相关性脑病的临床谱及基因型-表型相关性。
Brain. 2017 Sep 1;140(9):2337-2354. doi: 10.1093/brain/awx184.
5
Extracellular redox sensitivity of Kv1.2 potassium channels.Kv1.2 钾通道的细胞外氧化还原敏感性。
Sci Rep. 2017 Aug 22;7(1):9142. doi: 10.1038/s41598-017-08718-z.
6
Novel clinical manifestations in patients with KCNA2 mutations.患者 KCNA2 突变的新临床表现。
Seizure. 2017 Oct;51:74-76. doi: 10.1016/j.seizure.2017.07.018. Epub 2017 Aug 5.
7
Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.显性KCNA2突变导致发作性共济失调和药物反应性癫痫。
Neurology. 2016 Nov 8;87(19):1975-1984. doi: 10.1212/WNL.0000000000003309. Epub 2016 Oct 12.
8
Unexplained early onset epileptic encephalopathy: Exome screening and phenotype expansion.不明原因的早发性癫痫性脑病:外显子组筛查与表型扩展
Epilepsia. 2016 Jan;57(1):e12-7. doi: 10.1111/epi.13250. Epub 2015 Dec 9.
9
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.KCNA2基因的从头功能丧失或功能获得性突变会导致癫痫性脑病。
Nat Genet. 2015 Apr;47(4):393-399. doi: 10.1038/ng.3239. Epub 2015 Mar 9.
10
Use-dependent activation of neuronal Kv1.2 channel complexes.神经元Kv1.2通道复合物的使用依赖性激活。
J Neurosci. 2015 Feb 25;35(8):3515-24. doi: 10.1523/JNEUROSCI.4518-13.2015.